Pulmonary arterial hypertension (PAH) has been frequently compared with a type of
malignant disease and has an incredible number of pathogenic mechanisms similar to …

Pulmonary arterial hypertension (PAH) remains a mysterious killer that, like cancer, is
characterized by tremendous complexity. PAH development occurs under sustained and …

Pulmonary arterial hypertension (PAH) is a syndrome in which pulmonary arterial
obstruction increases pulmonary vascular resistance, which leads to right ventricular (RV) …

Pulmonary arterial hypertension (PAH) encompasses a group of clinical entities
characterized by sustained vasoconstriction and progressive vascular remodeling that act in …

Although the causal pathomechanisms contributing to remodelling of the pulmonary
vascular bed in pulmonary arterial hypertension (PAH) are still unclear, several analogous …

Pulmonary arterial hypertension (PAH) is a disease of the pulmonary vasculature
characterized by constricted and remodeled pulmonary arteries. This phenomenon is …

Persistent challenges in managing pulmonary vascular disease progression and poor
outcomes, despite the aggressive use of current drug therapies, highlight the need for …

In order to intervene appropriately and develop disease-modifying therapeutics for
pulmonary arterial hypertension, it is crucial to understand the mechanisms of disease …

Pulmonary hypertension (PH) is a complex pulmonary vascular condition with increasing
global prevalence and with particularly severe forms, such as pulmonary arterial …

Most patients with severe pulmonary arterial hypertension (PAH) at the time of diagnosis
tend to demonstrate persistent structural alterations in their microscopically small pulmonary …